DLL3 targeting peptides and constructs thereof
CR20260011APending Publication Date: 2026-05-15MARIANA ONCOLOGY INC
Patent Information
- Authority / Receiving Office
- CR · CR
- Patent Type
- Applications
- Current Assignee / Owner
- MARIANA ONCOLOGY INC
- Filing Date
- 2024-06-13
- Publication Date
- 2026-05-15
Abstract
The present disclosure relates to targeting moieties such as peptides that can bind to DLL3. The disclosure also provides targeting constructs, which may include a targeting moiety attached, via an optional linker, to a chelating agent for association of a cargo. Methods of making the constructs and formulations thereof are also provided. Methods of using the constructs and / or formulations thereof to treat subjects, for example, to treat or prevent cancer, are also described.
Need to check novelty before this filing date? Find Prior Art